Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 5.13%554.34M | 10.88%1.04B | 2.44%527.31M | -29.36%936.61M | -29.96%514.76M | 4.67%1.33B | 18.81%734.97M | 42.01%1.27B | 42.01%618.61M | 9.69%891.97M |
| Operating income | 5.13%554.34M | 10.88%1.04B | 2.44%527.31M | -29.36%936.61M | -29.96%514.76M | 4.67%1.33B | 18.81%734.97M | 42.01%1.27B | 42.01%618.61M | 9.69%891.97M |
| Cost of sales | -9.96%-489.7M | -14.59%-908.35M | -1.85%-445.32M | 28.10%-792.7M | 28.72%-437.22M | -3.33%-1.1B | -18.06%-613.43M | -36.31%-1.07B | -38.85%-519.6M | -10.65%-782.75M |
| Operating expenses | -9.96%-489.7M | -14.59%-908.35M | -1.85%-445.32M | 28.10%-792.7M | 28.72%-437.22M | -3.33%-1.1B | -18.06%-613.43M | -36.31%-1.07B | -38.85%-519.6M | -10.65%-782.75M |
| Gross profit | -21.16%64.64M | -9.54%130.18M | 5.74%81.99M | -35.55%143.91M | -36.20%77.54M | 11.84%223.29M | 22.76%121.54M | 82.81%199.66M | 61.30%99M | 3.26%109.22M |
| Selling expenses | -13.90%-54.51M | -28.53%-100.52M | -14.45%-47.86M | 20.21%-78.21M | 10.81%-41.81M | -19.65%-98.02M | -22.52%-46.88M | -15.55%-81.92M | -6.27%-38.26M | 1.82%-70.9M |
| Administrative expenses | 13.45%-19.76M | -33.84%-48.43M | -57.69%-22.83M | 8.06%-36.18M | 30.38%-14.48M | -21.39%-39.36M | -31.68%-20.8M | -17.99%-32.42M | -13.21%-15.8M | 0.79%-27.48M |
| Profit from asset sales | ---- | 158,119.46%3.25B | ---- | -100.47%-2.06M | ---- | 93,897.63%437.09M | --169.15M | --465K | ---- | ---- |
| Revaluation surplus | 7,698.25%1.34B | -74,097.70%-128.76M | --17.21M | --174K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Changes in the fair value of financial assets | 7,698.25%1.34B | -74,097.70%-128.76M | --17.21M | --174K | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provision | -690.99%-10.37M | 189.04%7.31M | 111.22%1.75M | 85.04%-8.21M | 55.92%-15.64M | -1,193.30%-54.85M | -603.91%-35.48M | ---4.24M | ---5.04M | ---- |
| -Other impairment is provision | -690.99%-10.37M | 189.04%7.31M | 111.22%1.75M | 85.04%-8.21M | 55.92%-15.64M | -1,193.30%-54.85M | -603.91%-35.48M | ---4.24M | ---5.04M | ---- |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | -74.75%-526K | ---632K | -29.18%-301K | ---- |
| Special items of operating profit | -10.35%33.91M | 75.86%51.53M | 110.04%37.83M | 58.20%29.3M | -29.04%18.01M | 24.77%18.52M | 216.08%25.38M | -32.45%14.85M | -1.93%8.03M | 627.66%21.98M |
| Operating profit | 1,891.70%1.36B | 6,380.68%3.16B | 188.34%68.09M | -89.99%48.74M | -88.88%23.61M | 408.28%486.68M | 345.86%212.38M | 191.75%95.75M | 145.89%47.63M | 2,538.18%32.82M |
| Financing cost | 90.24%-327K | -458.25%-6.43M | -484.47%-3.35M | -22.16%-1.15M | ---573K | ---943K | ---- | ---- | ---- | ---510K |
| Share of profits of associates | -143.47%-17.73M | -62.98%56.23M | -61.69%40.79M | -37.39%151.89M | -24.82%106.48M | 15.16%242.57M | 43.59%141.64M | 15.51%210.64M | 30.57%98.64M | 85.50%182.36M |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | --8.72M | ---- | ---- | ---- | ---- |
| Earning before tax | 1,167.89%1.34B | 1,508.45%3.21B | -18.52%105.53M | -72.94%199.47M | -63.41%129.52M | 140.55%737.03M | 142.02%354.02M | 42.73%306.39M | 54.11%146.28M | 46.84%214.67M |
| Tax | -1,183.51%-126.73M | -3,201.05%-419.1M | -0.05%-9.87M | 83.25%-12.7M | 76.62%-9.87M | -215.32%-75.79M | -191.49%-42.21M | -44.30%-24.04M | -56.96%-14.48M | -92.62%-16.66M |
| After-tax profit from continuing operations | 1,166.28%1.21B | 1,393.40%2.79B | -20.06%95.66M | -71.75%186.78M | -61.63%119.65M | 134.19%661.24M | 136.58%311.81M | 42.60%282.35M | 53.80%131.8M | 43.96%198.01M |
| Earning after tax | 1,166.28%1.21B | 1,393.40%2.79B | -20.06%95.66M | -71.75%186.78M | -61.63%119.65M | 134.19%661.24M | 136.58%311.81M | 42.60%282.35M | 53.80%131.8M | 43.96%198.01M |
| Minority profit | -378.92%-6.82M | -94.22%579K | -122.62%-1.42M | -78.30%10.01M | -54.87%6.29M | 192.47%46.14M | 38.31%13.94M | 53.50%15.77M | 128.27%10.08M | -25.10%10.28M |
| Profit attributable to shareholders | 1,154.74%1.22B | 1,477.66%2.79B | -14.36%97.08M | -71.26%176.76M | -61.94%113.36M | 130.74%615.11M | 144.72%297.87M | 42.00%266.58M | 49.76%121.72M | 51.62%187.73M |
| Basic earnings per share | 1,150.48%1.313 | 1,504.28%3 | -11.76%0.105 | -70.60%0.187 | -61.11%0.119 | 132.97%0.636 | 146.77%0.306 | 42.93%0.273 | 49.40%0.124 | 52.80%0.191 |
| Diluted earnings per share | 1,146.67%1.309 | 1,504.84%2.985 | -11.76%0.105 | -70.57%0.186 | -60.86%0.119 | 133.21%0.632 | 145.16%0.304 | 42.63%0.271 | 49.40%0.124 | 52.00%0.19 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.